Clinical Trial Update: Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study [Phase 2]

View source ↗

Summary

Phase 2 rollover trial update for placebo subjects previously enrolled in GEN-003-002 in genital herpes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• GEN-003

Snippet

Sponsor: Genocea Biosciences, Inc. | Conditions: Genital Herpes Simplex Type 2 | Phase 2 | Status: COMPLETED